Latest Antiretroviral drug Stories
PITTSBURGH and LONDON, Dec. 4, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Laboratories Limited has received tentative approval from the U.S.
The ability of HIV to cause AIDS is weakening, and the virus is becoming less deadly and less infectious as it adapts to our immune systems, according to new research published Monday in the journal Proceedings of the National Academy of Sciences.
BIRMINGHAM, Ala., Dec.
PITTSBURGH and HYDERABAD, India, Dec. 1, 2014 /PRNewswire/ -- Mylan Inc.
December 1st is World AIDS day.
GENEVA, December 1, 2014 /PRNewswire/ -- Licence will support the work of the recently launched Paediatric HIV Treatment Initiative (PHTI) to Develop Better Adapted
New study finds that two-thirds of Americans with virus not in check have been diagnosed, but were no longer in care ATLANTA, Nov.
PITTSBURGH, Oct. 30, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced the U.S.
VANCOUVER, Oct. 22, 2014 /PRNewswire/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) (OTCQX: ICOTF), today announced next steps for its Oral Amphotericin B program.
Human immunodeficiency virus (HIV), a lentivirus, causes acquired immunodeficiency syndrome (AIDS) which is a condition in humans were the immune system begins to fail, leading to life-threatening opportunistic infections. Infection is transferred through bodily fluids where HIV is present as both free virus particles and within infected immune cells. The four most common routes of infection are unsafe sex, contaminated needles, breast milk, and transmission from an infected mother to her...
- An imitative word; an onomatopoetic word.